The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...

Leading German laboratories ProGraphite and Dorfner Anzaplan have confirmed Kasiya Rutile- Graphite Project qualification for refractory applications. Sovereign Metals Limited, the firm behind the ...

ASX-listed Sovereign Metals has reported that testwork completed on graphite from its Kasiya rutile/graphite project, in Malawi, has confirmed that the project’s graphite has the key characteristics ...

Sovereign Metals has confirmed that graphite concentrate from its Kasiya project in Malawi is of refractory-grade quality. Refractories, the heat resistant ...

(Alliance News) - Sovereign Metals Ltd on Wednesday said testing has confirmed that graphite from its Kasiya rutile-graphite project in Malawi meets the requirements for use in refractory applications ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

Learn more about whether Minerals Technologies Inc. or Sasol Limited is a better investment based on AAII's A+ Investor ...

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology firm specializing in allogeneic CAR T therapies currently valued at approximately $299 million, has published new data ...